SCHEMBL4940502

SCHEMBL4940502

O=S(=O)(c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O)N1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.47
ALDH1A1 P00352 3/20 0.45
HTT P42858 2/20 0.45
MAPT P10636 2/20 0.45
GAA P10253 1/20 0.45
PKM P14618 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CHRM4 P08173 2/20 0.43
GFER P55789 3/20 0.42
TSHR P16473 3/20 0.41
COMT P21964 3/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.39
ALOX15 P16050 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4941311 0.90 HSP90AA1 (0.48) HSP90AA1ALDH1A1MAPTGAAGFER
SCHEMBL4941553 0.84 ALDH1A1 (0.50) ALDH1A1MAPTGAAMAPK1SMN1; SMN2
SCHEMBL4937635 0.81 HSP90AA1 (0.41) HSP90AA1ALDH1A1HTTMAPTGAA
SCHEMBL4939580 0.81 HSP90AA1 (0.58) HSP90AA1ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL4936289 0.81 HSP90AA1 (0.48) HSP90AA1ALDH1A1HTTGAATSHR
SCHEMBL4941503 0.79 HSP90AA1 (0.51) HSP90AA1ALDH1A1HTTMAPTGAA
SCHEMBL4943270 0.79 HSP90AA1 (0.45) HSP90AA1ALDH1A1MAPTKDM4E
SCHEMBL4939553 0.79 HSP90AA1 (0.70) HSP90AA1ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL4940684 0.78 HSP90AA1 (0.53) HSP90AA1ALDH1A1HTTMAPTGAA
SCHEMBL4933407 0.77 HSP90AA1 (0.55) HSP90AA1ALDH1A1HTTMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP claimed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US claimed
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP disclosed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US disclosed
EP-1853570-A2 HSP90-INHIBITING TRIAZOLE DERIVATIVES Merck Patent GmbH (DE) 2007-11-14 EP disclosed
WO-2006087077-A2 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2006-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182857-A1 Triazole Derivatives HSP90AB1, HSP90AA1, HSP90B1 HSP90AA1 2/4885ALDH1A1 1580/4885HTT 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.